Wednesday April 14, 2021
  • |Subscribe
  • |Contribute
  • |About
  • |Access Your Account
  • |Register
  • |Login
  • |Home
  • |Current Issue
  • |Issue Archive
    • |Featured Reports
    • |eBooks
  • |BioProcess Insider
  • |Multimedia
    • |BPI White Papers
    • |Webinars
    • |Posters
  • |BioProcess International Events
    • |BioProcess International West
    • |COVID-19 Therapeutic Development & Production
  • |BioProcess International Academy
  • |Events

BioProcess International

Covering the whole development process for the global biotechnology industry

  • Upstream
    Processing
    Bioprocessing begins upstream, most often with culturing of animal or microbial cells in a range of vessel types (such as bags or stirred tanks) using different controlled feeding, aerating, and process strategies.
    • Assays
    • Biochemicals/Raw Materials
    • Bioreactors
    • Cell Culture Media
    • Expression Platforms
    • Fermentation
    • Perfusion Cell Culture
    • Upstream Contract Services
    • Upstream Single-Use Technologies
  • Downstream
    Processing
    Beginning with harvest of material from a bioreactor, downstream processing removes or reduces contaminants to acceptable levels through several steps that typically include centrifugation, filtration, and/or chromatographic technologies.
    • Filtration
    • Separation/Purification
    • Viral Clearance
    • Chromatography
    • Downstream Contract Services
    • Downstream Single-Use Technologies
  • Manufacturing
    Drug products combine active pharmaceutical ingredients with excipients in a final formulation for delivery to patients in liquid or lyophilized (freeze-dried) packaged forms — with the latter requiring reconstitution in the clinical setting.
    • Personalized Medicine
    • Single Use
    • Supply Chain
    • Vaccines
    • MAb
    • Biosimilars
    • Cell/Gene Therapies
    • Emerging Therapeutics
    • Facility Design/Engineering
    • Continuous Bioprocessing
    • Fill/Finish
    • Formulation
    • Information Technology
    • Manufacturing Contract Services
    • Process Monitoring and Controls
  • Analytical
    Many technologies are used to characterize biological products, manufacturing processes, and raw materials. The number of options and applications is growing every day — with quality by design (QbD) giving impetus to this expansion.
    • Culture Development
    • Cell Line Development
    • Downstream Development
    • Downstream Validation
    • Laboratory Equipment
    • PAT
    • Pre-Formulation
    • Product Characterization
    • QA/QC
    • Upstream Development
    • Upstream Validation
    • Leachables/Extractables/Particulates
  • Business
    Even as it matures, the biopharmaceutical industry is still a highly entrepreneurial one. Partnerships of many kinds — from outsourcing to licensing agreements to consultancies — help companies navigate this increasingly global business environment.
    • Careers
    • CMC Forums
    • Economics
    • Intellectual Property
    • Pre-Clinical and Clinical Trials
    • Regulatory Affairs
    • Risk Management
    • BioRegions

Monday, October 1, 2007 Daily Archives

Biopharmaceutical Manufacturing and Development (BMD) Summit

by BPI Contributor
Add Comment
October 1, 2007

Bioprocessing in the 21st Century

by BPI Contributor
Add Comment
October 1, 2007

Biosimilars and the Changing Environment of Regulation and Reimbursement

by BPI Contributor
Add Comment
October 1, 2007

BPI Reports

by BPI Contributor
Add Comment
October 1, 2007

Elevating Standard ELISA Technology By Sterilizing Pipet Tips with “Cold” Atmospheric Plasma

by BPI Contributor
Add Comment
October 1, 2007

Formulation and Delivery

by BPI Contributor
Add Comment
October 1, 2007

Guide to Irradiation and Sterilization Validation of Single-Use Bioprocess Systems, Part 2

by BPI Contributor
Add Comment
October 1, 2007

It’s About Time!

by BPI Contributor
Add Comment
October 1, 2007

Many Choices in Expression

by BPI Contributor
Add Comment
October 1, 2007

Our Readers Respond

by BPI Contributor
Add Comment
October 1, 2007
  • 1
  • 2
  • 3
  • >

Editor’s Choice

  • BioProcess Insider

    Horseshoe crabs: COVID-19 further threat to ‘blue blood’ of industry

  • BioProcess Insider

    Catalent: ‘Dedicated Moderna line frees space for our non-COVID customers’

  • Sponsored Content

    CHO Cell Culture Media & Feeds

  • BioProcess Insider

    Sanofi to build $700m Canadian flu vaccine plant

  • BioProcess Insider

    Turning a corner in CAR-T: FDA approves ide-cel

  • Sponsored Content

    Crude Sample Analysis in Process Development: Time and Cost Savings

BioProcess Insider News and Analysis

Recent Tweets

  • Tweet Avatar RT @Dan5tanton: As part of a “difficult decision” to halt its biosimilars programs in China, Pfizer is offloading its single-use bi… https://t.co/vsE7WAknKd 4 weeks ago
  • Tweet Avatar RT @Dan5tanton: Thermo Fisher’s $600 million CAPEX has got the trade press salivating. But similar statements, expansions underway,… https://t.co/5xHNdfJwRw 1 month ago
  • Tweet Avatar RT @Dan5tanton: Calls for standardization to boost manufacturing agility by executives from Novavax, Fujifilm, and Biocon after a C… https://t.co/UJO2CH09K8 1 month ago
  • Tweet Avatar VIVEbiotech has responded to the high demand for lentiviral vectors in the cell and gene therapy space by expanding… https://t.co/y11zPEBs0E 2 months ago
Follow @bioproinsider

Trending

  • BioProcess Insider

    Lonza dedicates suite to make Altimmune’s nasal COVID-19 vaccine

  • BioProcess Insider

    Lifecycle approach could cut cell and gene therapy costs

  • BioProcess Insider

    WuXi Bio set for 430,000 L biomanufacturing capacity from 2024

  • BioProcess Insider

    BIO: Sputnik V should be judged on same data as other COVID jabs

Explore Topics

  • Upstream Processing
  • Downstream Processing
  • Manufacturing
  • Analytical
  • Business

Publication

  • Issue Archive
  • Featured Reports
  • eBooks
  • Subscribe
Connect
Privacy policy

BioProcessIntl.com

  • White Papers
  • Posters
  • Webinars
  • BPI Theater
  • Awards
  • Register
  • Login
  • Access Your Account

Keep up with BPI

  • Email Newsletters
  • Events
  • BioProcess Insider
  • Twitter
  • LinkedIn

About BPI

  • Who We Are
  • Editorial Advisors
  • Author Guidelines
  • Advertising/Media Kit
  • List Rental/Reprints
  • Contact Us
  • Careers
BPI
twitter linkedin
Site Map|Contact
©2021 BioProcess International All Rights reserved
  • Home
  • Current Issue
  • Issue Archive
    ▼
    • Featured Reports
    • eBooks
  • BioProcess Insider
  • Multimedia
    ▼
    • BPI White Papers
    • Webinars
    • Posters
  • BioProcess International Events
    ▼
    • BioProcess International West
    • COVID-19 Therapeutic Development & Production
  • BioProcess International Academy
  • Events